Garrick C Stewart
Overview
Explore the profile of Garrick C Stewart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Dunlay S, Pinney S, Lala A, Stewart G, McIlvennan C, Wong R, et al.
JAMA Cardiol
. 2025 Feb;
PMID: 39908057
Importance: The advanced ambulatory heart failure (HF) population comprises patients who have progressed beyond the pillars of recommended stage C HF therapies but can still find meaningful life-years ahead. Although...
3.
Sayer G, Ahmed M, Mehra M, Gosev I, Vidula H, DeVore A, et al.
J Card Fail
. 2025 Jan;
PMID: 39855458
Background: The benefit of implantable cardioverter-defibrillators (ICDs) and cardiovascular resynchronization therapy defibrillators (CRT-Ds) in patients supported with a HeartMate 3 left ventricular assist device (LVAD) remains uncertain. Methods: An analysis...
4.
5.
Aaronson K, Stewart G, Stevenson L, Richards B, Khalatbari S, Cascino T, et al.
JACC Heart Fail
. 2024 Jul;
12(10):1734-1746.
PMID: 38970587
Background: Left ventricular assist device (LVAD) use remains uncommon in advanced heart failure (HF) patients not dependent on inotropes. Objectives: Before considering a randomized trial comparing a strategy of earlier...
6.
Rali A, Inampudi C, Zalawadiya S, Shah A, Teuteberg J, Stewart G, et al.
J Card Fail
. 2023 Oct;
30(4):552-561.
PMID: 37898382
Background: Left ventricular assist devices (LVADs) have been implanted as bridge to transplantation (BTT), bridge to candidacy (BTC) or destination therapy (DT) on the basis of relative and absolute contraindications...
7.
Wert L, Stewart G, Mehra M, Milwidsky A, Jorde U, Goldstein D, et al.
J Thorac Cardiovasc Surg
. 2022 Dec;
167(4):1322-1330.e6.
PMID: 36562497
Background: The HeartMate 3 (HM 3; Abbott) left ventricular assist device (LVAD) has improved hemocompatibility-related adverse outcomes. In sporadic cases, external compression of the outflow graft causing obstruction (eOGO) can...
8.
Cascino T, Colvin M, Lanfear D, Richards B, Khalatbari S, Mann D, et al.
Circ Heart Fail
. 2022 Oct;
16(1):e009745.
PMID: 36259388
Background: Racial disparities in access to advanced therapies for heart failure (HF) patients are well documented, although the reasons remain uncertain. We sought to determine the association of race on...
9.
Lala A, Shah P, Khalatbari S, Yosef M, Mountis M, Robinson S, et al.
J Card Fail
. 2021 Dec;
28(5):765-774.
PMID: 34961663
Background: The Fried Frailty Phenotype predicts adverse outcomes in geriatric populations, but has not been well-studied in advanced heart failure (HF). The Registry Evaluation of Vital Information for Ventricular Assist...
10.
Giblin G, Murphy L, Stewart G, Desai A, Di Carli M, Blankstein R, et al.
Card Fail Rev
. 2021 Dec;
7:e17.
PMID: 34950507
Sarcoidosis is a complex, multisystem inflammatory disease with a heterogeneous clinical spectrum. Approximately 25% of patients with systemic sarcoidosis will have cardiac involvement that portends a poorer outcome. The diagnosis,...